Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aptevo Therapeutics Inc
(NQ:
APVO
)
0.8380
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptevo Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
5 Value Stocks In The Healthcare Sector
December 05, 2022
Via
Benzinga
Aptevo Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
November 10, 2022
Via
ACCESSWIRE
Alligator Bioscience & Aptevo Therapeutics Announce Publication Highlighting ALG.APV-527 Preclinical Data in Peer-Reviewed Journal Molecular Cancer Therapeutics
November 09, 2022
Via
ACCESSWIRE
Aptevo Therapeutics Announces Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
November 03, 2022
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued a "May Proceed" Notification for the ALG.APV-527 IND
September 19, 2022
Via
ACCESSWIRE
Aptevo Therapeutics: Q2 Earnings Insights
August 11, 2022
Aptevo Therapeutics (NASDAQ:APVO) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: Aptevo Therapeutics Q1 Earnings
May 12, 2022
Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Are Aptevo Therapeutics Shares Trading Higher Today?
February 09, 2022
Aptevo Therapeutics Inc (NASDAQ: APVO)
Via
Benzinga
Aptevo Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
August 11, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 23, 2022
Via
Benzinga
91 Biggest Movers From Friday
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 10, 2022
Via
Benzinga
Aptevo Therapeutics Announces New Preliminary Remission Data on Four Additional Patients Enrolled in On-going APVO436 Dose Expansion Phase 1b Trial for the Treatment of Acute Myeloid Leukemia
June 09, 2022
Cohort 1 Combination Therapy Arm Shows 36% Remission Rate Among Response-evaluable Patients Treated to Date
From
Aptevo Therapeutics
Via
AccessWire
Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
May 12, 2022
SEATTLE, WA / ACCESSWIRE / May 12, 2022 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology...
From
Aptevo Therapeutics
Via
AccessWire
APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting
April 12, 2022
Preclinical Data Support Potential for APVO442 in Difficult-to-Treat Types of Prostate Cancer, Including Metastatic Castration-Resistant Disease SEATTLE, WA / ACCESSWIRE / April 12, 2022 / Aptevo...
From
Aptevo Therapeutics
Via
AccessWire
Aptevo Therapeutics Announces Monotherapy Patient Received a Transplant in APVO436 Expansion Trial for the Treatment of Acute Myeloid Leukemia
March 29, 2022
Patients in Both Monotherapy and Combination Arms in Multi-Cohort Trial Have Achieved Transplant Eligible Status SEATTLE, WA / ACCESSWIRE / March 29, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a...
From
Aptevo Therapeutics
Via
AccessWire
Aptevo Therapeutics Earnings Perspective: Return On Capital Employed
March 25, 2022
According to Benzinga Pro data, during Q4, Aptevo Therapeutics (NASDAQ:APVO) posted sales of $3.67 million. Earnings were up 10.36%, but Aptevo Therapeutics still reported an...
Via
Benzinga
63 Biggest Movers From Yesterday
March 25, 2022
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 150 Points; Emclaire Financial Shares Spike Higher
March 24, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq composite gaining over 150 points on Thursday. The Dow traded up 0.76% to 34,621.33 while the NASDAQ rose 1.19...
Via
Benzinga
Why Did Aptevo Therapeutics Stock Jump 25% Today?
March 24, 2022
Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher Thursday after the company reported 2021 financial results. Aptevo said royalty revenue totaled $...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8...
Via
Benzinga
Mid-Day Market Update: Dow Surges 250 Points; LiqTech International Shares Slide
March 24, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones jumping 250 points on Thursday. The Dow traded up 0.75% to 34,617.38 while the NASDAQ rose 1.08% to 14,072.31...
Via
Benzinga
34 Stocks Moving In Thursday's Mid-Day Session
March 24, 2022
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and...
Via
Benzinga
Aptevo Therapeutics: Q4 Earnings Insights
March 24, 2022
Aptevo Therapeutics (NASDAQ:APVO) reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Aptevo Therapeutics Reports 2021 Financial Results and Provides Business Update
March 24, 2022
SEATTLE, WA / ACCESSWIRE / March 24, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its...
From
Aptevo Therapeutics
Via
AccessWire
60 Biggest Movers From Yesterday
February 10, 2022
Gainers US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash....
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 09, 2022
Gainers US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash. Tritium DCFC Limited (...
Via
Benzinga
Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update
February 09, 2022
APVO436 Phase 1b Trial for Acute Myeloid Leukemia Adds New Site Complete Remission Patient to Advance to Transplant SEATTLE, WA / ACCESSWIRE / February 9, 2022 / Aptevo Therapeutics Inc. ("Aptevo" or...
From
Aptevo Therapeutics
Via
AccessWire
12 Health Care Stocks Moving In Monday's After-Market Session
January 24, 2022
Gainers Aptorum Group (NASDAQ:APM) stock m...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.